Literature DB >> 28715404

An IL-8 Transiently Transgenized Mouse Model for the In Vivo Long-term Monitoring of Inflammatory Responses.

Gabriella Bergamini1, Fabio Stellari2, Angela Sandri3, Maria M Lleo3, Gaetano Donofrio4, Francesca Ruscitti5, Federico Boschi6, Andrea Sbarbati7, Gino Villetti2, Paola Melotti8, Claudio Sorio9.   

Abstract

Airway inflammation is often associated with bacterial infections and represents a major determinant of lung disease. The in vivo determination of the pro-inflammatory capabilities of various factors is challenging and requires terminal procedures, such as bronchoalveolar lavage and the removal of lungs for in situ analysis, precluding longitudinal visualization in the same mouse. Here, lung inflammation is induced through the intratracheal instillation of Pseudomonas aeruginosa culture supernatant (SN) in transiently transgenized mice expressing the luciferase reporter gene under the control of a heterologous IL-8 bovine promoter. Luciferase expression in the lung is monitored by in vivo bioluminescent image (BLI) analysis over a 2.5- to 48-h timeframe following the instillation. The procedure can be repeated multiple times within 2 - 3 months, thus permitting the evaluation of the inflammatory response in the same mice without the need to terminate the animals. This approach permits the monitoring of pro- and anti-inflammatory factors acting in the lung in real time and appears suitable for functional and pharmacological studies.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28715404      PMCID: PMC5609320          DOI: 10.3791/55499

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  12 in total

Review 1.  Lung inflammation in cystic fibrosis: pathogenesis and novel therapies.

Authors:  Barbara Dhooghe; Sabrina Noël; François Huaux; Teresinha Leal
Journal:  Clin Biochem       Date:  2013-12-29       Impact factor: 3.281

2.  Neutrophil and B cell expansion in mice that lack the murine IL-8 receptor homolog.

Authors:  G Cacalano; J Lee; K Kikly; A M Ryan; S Pitts-Meek; B Hultgren; W I Wood; M W Moore
Journal:  Science       Date:  1994-07-29       Impact factor: 47.728

Review 3.  Airway inflammation in cystic fibrosis: molecular mechanisms and clinical implications.

Authors:  Malena Cohen-Cymberknoh; Eitan Kerem; Thomas Ferkol; Arnon Elizur
Journal:  Thorax       Date:  2013-05-23       Impact factor: 9.139

Review 4.  Noninvasive biomarkers of airway inflammation in cystic fibrosis.

Authors:  Scott D Sagel
Journal:  Curr Opin Pulm Med       Date:  2003-11       Impact factor: 3.155

Review 5.  Therapeutic approaches to asthma-chronic obstructive pulmonary disease overlap syndromes.

Authors:  Peter J Barnes
Journal:  J Allergy Clin Immunol       Date:  2015-09       Impact factor: 10.793

6.  Long-term impaired neutrophil migration in mice overexpressing human interleukin-8.

Authors:  W S Simonet; T M Hughes; H Q Nguyen; L D Trebasky; D M Danilenko; E S Medlock
Journal:  J Clin Invest       Date:  1994-09       Impact factor: 14.808

7.  In vivo imaging of transiently transgenized mice with a bovine interleukin 8 (CXCL8) promoter/luciferase reporter construct.

Authors:  Fabio Franco Stellari; Valentina Franceschi; Antonio Capocefalo; Marcello Ronchei; Fabrizio Facchinetti; Gino Villetti; Gaetano Donofrio
Journal:  PLoS One       Date:  2012-06-28       Impact factor: 3.240

8.  Host genetic background influences the response to the opportunistic Pseudomonas aeruginosa infection altering cell-mediated immunity and bacterial replication.

Authors:  Maura De Simone; Lorenza Spagnuolo; Nicola Ivan Lorè; Giacomo Rossi; Cristina Cigana; Ida De Fino; Fuad A Iraqi; Alessandra Bragonzi
Journal:  PLoS One       Date:  2014-09-30       Impact factor: 3.240

9.  In vivo imaging of the lung inflammatory response to Pseudomonas aeruginosa and its modulation by azithromycin.

Authors:  Fabio Stellari; Gabriella Bergamini; Angela Sandri; Gaetano Donofrio; Claudio Sorio; Francesca Ruscitti; Gino Villetti; Barouk M Assael; Paola Melotti; Maria M Lleo
Journal:  J Transl Med       Date:  2015-08-04       Impact factor: 5.531

Review 10.  Targeted anti-inflammatory therapeutics in asthma and chronic obstructive lung disease.

Authors:  Andrew L Durham; Gaetano Caramori; Kian F Chung; Ian M Adcock
Journal:  Transl Res       Date:  2015-08-20       Impact factor: 7.012

View more
  3 in total

1.  Protease inhibitors elicit anti-inflammatory effects in CF mice with Pseudomonas aeruginosa acute lung infection.

Authors:  A Sandri; M M Lleo; C Signoretto; M Boaretti; F Boschi
Journal:  Clin Exp Immunol       Date:  2020-10-12       Impact factor: 4.330

2.  Mouse pneumonia model by Acinetobacter baumannii multidrug resistant strains: Comparison between intranasal inoculation, intratracheal instillation and oropharyngeal aspiration techniques.

Authors:  Gabriella Bergamini; Maria Elisa Perico; Stefano Di Palma; Daniela Sabatini; Filippo Andreetta; Rossella Defazio; Antonio Felici; Livia Ferrari
Journal:  PLoS One       Date:  2021-12-02       Impact factor: 3.240

3.  Inhibition of Pseudomonas aeruginosa secreted virulence factors reduces lung inflammation in CF mice.

Authors:  Angela Sandri; Alessia Ortombina; Federico Boschi; Eleonora Cremonini; Marzia Boaretti; Claudio Sorio; Paola Melotti; Gabriella Bergamini; Maria Lleo
Journal:  Virulence       Date:  2018       Impact factor: 5.882

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.